149 related articles for article (PubMed ID: 9272198)
1. Double-blind randomized controlled study of the efficacy and tolerability of two reversible monoamine oxidase A inhibitors, pirlindole and moclobemide, in the treatment of depression.
Tanghe A; Geerts S; Van Dorpe J; Brichard B; Bruhwyler J; Géczy J
Acta Psychiatr Scand; 1997 Aug; 96(2):134-41. PubMed ID: 9272198
[TBL] [Abstract][Full Text] [Related]
2. A double-blind randomized placebo-controlled study of the efficacy and safety of pirlindole, a reversible monoamine oxidase A inhibitor, in the treatment of depression.
De Wilde JE; Geerts S; Van Dorpe J; Bruhwyler J; Géczy J
Acta Psychiatr Scand; 1996 Dec; 94(6):404-10. PubMed ID: 9020990
[TBL] [Abstract][Full Text] [Related]
3. Initial monoamine oxidase-A inhibition by moclobemide does not predict the therapeutic response in patients with major depression. A double blind, randomized study.
Radat F; Berlin I; Spreux-Varoquaux O; Elatki S; Ferreri M; Puech AJ
Psychopharmacology (Berl); 1996 Oct; 127(4):370-6. PubMed ID: 8923574
[TBL] [Abstract][Full Text] [Related]
4. Moclobemide and imipramine in chronic depression (dysthymia): an international double-blind, placebo-controlled trial. International Collaborative Study Group.
Versiani M; Amrein R; Stabl M
Int Clin Psychopharmacol; 1997 Jul; 12(4):183-93. PubMed ID: 9347378
[TBL] [Abstract][Full Text] [Related]
5. A controlled double-blind trial of moclobemide and imipramine in the treatment of depression.
Kok LP; Tsoi WF
Singapore Med J; 1995 Feb; 36(1):38-40. PubMed ID: 7570133
[TBL] [Abstract][Full Text] [Related]
6. Moclobemide versus clomipramine in the treatment of depression: a multicentre trial in Spain.
Civeira J; Cervera S; Giner J; Allen SR; Hellstern K; Malanowski H; Wirz R; Klar K
Acta Psychiatr Scand Suppl; 1990; 360():48-9. PubMed ID: 2248070
[TBL] [Abstract][Full Text] [Related]
7. Moclobemide versus fluoxetine for double depression: a randomized double-blind study.
Duarte A; Mikkelsen H; Delini-Stula A
J Psychiatr Res; 1996; 30(6):453-8. PubMed ID: 9023788
[TBL] [Abstract][Full Text] [Related]
8. A reversible monoamine oxidase A inhibitor (moclobemide) facilitates smoking cessation and abstinence in heavy, dependent smokers.
Berlin I; Saïd S; Spreux-Varoquaux O; Launay JM; Olivares R; Millet V; Lecrubier Y; Puech AJ
Clin Pharmacol Ther; 1995 Oct; 58(4):444-52. PubMed ID: 7586937
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of reversible inhibitors of monoamine oxidase-A in various forms of depression.
Lecrubier Y; Guelfi JD
Acta Psychiatr Scand Suppl; 1990; 360():18-23. PubMed ID: 2248063
[TBL] [Abstract][Full Text] [Related]
10. Multicenter double-blind study of moclobemide and maprotiline.
Vaz-Serra A; Figueira ML; Firmino H; Albuquerque AJ; Jara JM; Pestana LC
Clin Neuropharmacol; 1994; 17 Suppl 1():S38-49. PubMed ID: 7954483
[TBL] [Abstract][Full Text] [Related]
11. Moclobemide versus clomipramine in the treatment of depression: a single-centre study, Federal Republic of Germany.
Funke HJ; Moritz E; Hellstern K; Malanowski H
Acta Psychiatr Scand Suppl; 1990; 360():46-7. PubMed ID: 2248069
[TBL] [Abstract][Full Text] [Related]
12. Moclobemide, imipramine and placebo in the treatment of major depression.
Versiani M; Nardi AE; Mundim FD; Alves A; Schmid-Burgk W
Acta Psychiatr Scand Suppl; 1990; 360():57-8. PubMed ID: 2248073
[TBL] [Abstract][Full Text] [Related]
13. A multicentre comparative trial of moclobemide, imipramine and placebo in major depressive disorder. UK Moclobemide Study Group.
Int Clin Psychopharmacol; 1994; 9(2):109-13. PubMed ID: 8056992
[TBL] [Abstract][Full Text] [Related]
14. Moclobemide versus clomipramine in the treatment of depression: a double-blind multicentre study in Belgium.
Dierick M; Cattiez P; Franck G; Burton P; Defleur J; Hermans W; Roelandts A; Wolfrum C; Berger M; Hellstern K
Acta Psychiatr Scand Suppl; 1990; 360():50-1. PubMed ID: 2248071
[TBL] [Abstract][Full Text] [Related]
15. Dimensional assessment of onset of action of antidepressants: a comparative study of moclobemide vs. clomipramine in depressed patients with blunted affect and psychomotor retardation.
Jouvent R; Le Houezec J; Payan C; Mikkelsen H; Fermanian J; Millet V; Dufour H
Psychiatry Res; 1998 Jul; 79(3):267-75. PubMed ID: 9704873
[TBL] [Abstract][Full Text] [Related]
16. Moclobemide versus clomipramine in endogenous depression. A double-blind randomised clinical trial.
Guelfi JD; Payan C; Fermanian J; Pedarriosse AM; Manfredi R
Br J Psychiatry; 1992 Apr; 160():519-24. PubMed ID: 1571752
[TBL] [Abstract][Full Text] [Related]
17. Double-blind comparison of moclobemide and tranylcypromine in depression.
Heinze G; Rossel L; Gabelic I; Galeano-Munoz J; Stabl M; Allen SR
Pharmacopsychiatry; 1993 Nov; 26(6):240-5. PubMed ID: 8127928
[TBL] [Abstract][Full Text] [Related]
18. Moclobemide (Ro 11-1163) versus imipramine in the treatment of depression.
Casacchia M; Moll E
Acta Psychiatr Scand Suppl; 1990; 360():43. PubMed ID: 2248067
[TBL] [Abstract][Full Text] [Related]
19. Moclobemide versus clomipramine in nonmelancholic, nonpsychotic major depression. A Study group.
Lecrubier Y; Pedarriosse AM; Payan C; Schmid-Burgk W; Stabl M
Acta Psychiatr Scand; 1995 Oct; 92(4):260-5. PubMed ID: 8848950
[TBL] [Abstract][Full Text] [Related]
20. Pirlindole in the treatment of depression: a meta-analysis.
Macedo A; Leiria E; Filipe A
Clin Drug Investig; 2011; 31(1):61-71. PubMed ID: 21053988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]